Clarithromycin Tablet, Film Coated, Extended Release
Product Images NDC 0591-2805

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 0591-2805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

2 (Image 2)

2 (Image 2)
FDA Label Image

3 (Image 3)

3 (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
FDA Label Image

1 (Image 5)

1 (Image 5)
NDC 0591-2805-60 is a medication with 500mg of Clarithromycin, USP per film-coated tablet. It should be dispensed in a USP tight container, and the usual dosage is two tablets once daily. The text mentions extended-release tablets, but it is not clear if these are the same as the film-coated tablets. The product is distributed by Actavis in the USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.